D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>

FimH is a type I fimbria of uropathogenic <i>Escherichia coli</i> (UPEC), recognized for its ability to adhere and infect epithelial urinary tissue. Due to its role in the virulence of UPEC, several therapeutic strategies have focused on the study of FimH, including vaccines, mannosides,...

Full description

Bibliographic Details
Main Authors: Alfredo Montes-Robledo, Rosa Baldiris-Avila, Johan Fabian Galindo
Format: Article
Language:English
Published: MDPI AG 2021-09-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/9/1072
_version_ 1797520464471392256
author Alfredo Montes-Robledo
Rosa Baldiris-Avila
Johan Fabian Galindo
author_facet Alfredo Montes-Robledo
Rosa Baldiris-Avila
Johan Fabian Galindo
author_sort Alfredo Montes-Robledo
collection DOAJ
description FimH is a type I fimbria of uropathogenic <i>Escherichia coli</i> (UPEC), recognized for its ability to adhere and infect epithelial urinary tissue. Due to its role in the virulence of UPEC, several therapeutic strategies have focused on the study of FimH, including vaccines, mannosides, and molecules that inhibit their assembly. This work has focused on the ability of a set of monosubstituted and disubstituted phenyl mannosides to inhibit FimH. To determine the 3D structure of FimH for our in silico studies, we obtained fifteen sequences by PCR amplification of the <i>fimH</i> gene from 102 UPEC isolates. The <i>fimH</i> sequences in BLAST had a high homology (97–100%) to our UPEC <i>fimH</i> sequences. A search for the three-dimensional crystallographic structure of FimH proteins in the PDB server showed that proteins 4X5P and 4XO9 were found in 10 of the 15 isolates, presenting a 67% influx among our UPEC isolates. We focused on these two proteins to study the stability, free energy, and the interactions with different mannoside ligands. We found that the interactions with the residues of aspartic acid (ASP 54) and glutamine (GLN 133) were significant to the binding stability. The ligands assessed demonstrated high binding affinity and stability with the lectin domain of FimH proteins during the molecular dynamic simulations, based on MM-PBSA analysis. Therefore, our results suggest the potential utility of phenyl mannoside derivatives as FimH inhibitors to mitigate urinary tract infections produced by UPEC; thus, decreasing colonization, disease burden, and the costs of medical care.
first_indexed 2024-03-10T07:57:08Z
format Article
id doaj.art-7b1e024519f042d193d6a75d975c0fef
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T07:57:08Z
publishDate 2021-09-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-7b1e024519f042d193d6a75d975c0fef2023-11-22T11:45:49ZengMDPI AGAntibiotics2079-63822021-09-01109107210.3390/antibiotics10091072D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>Alfredo Montes-Robledo0Rosa Baldiris-Avila1Johan Fabian Galindo2Grupo de Investigación Microbiología Clínica y Ambiental, Facultad de Ciencias Exactas y Naturales, Universidad de Cartagena, Cartagena de Indias 13001, ColombiaGrupo de Investigación Microbiología Clínica y Ambiental, Facultad de Ciencias Exactas y Naturales, Universidad de Cartagena, Cartagena de Indias 13001, ColombiaDepartamento de Química, Universidad Nacional de Colombia, Bogotá 11321, ColombiaFimH is a type I fimbria of uropathogenic <i>Escherichia coli</i> (UPEC), recognized for its ability to adhere and infect epithelial urinary tissue. Due to its role in the virulence of UPEC, several therapeutic strategies have focused on the study of FimH, including vaccines, mannosides, and molecules that inhibit their assembly. This work has focused on the ability of a set of monosubstituted and disubstituted phenyl mannosides to inhibit FimH. To determine the 3D structure of FimH for our in silico studies, we obtained fifteen sequences by PCR amplification of the <i>fimH</i> gene from 102 UPEC isolates. The <i>fimH</i> sequences in BLAST had a high homology (97–100%) to our UPEC <i>fimH</i> sequences. A search for the three-dimensional crystallographic structure of FimH proteins in the PDB server showed that proteins 4X5P and 4XO9 were found in 10 of the 15 isolates, presenting a 67% influx among our UPEC isolates. We focused on these two proteins to study the stability, free energy, and the interactions with different mannoside ligands. We found that the interactions with the residues of aspartic acid (ASP 54) and glutamine (GLN 133) were significant to the binding stability. The ligands assessed demonstrated high binding affinity and stability with the lectin domain of FimH proteins during the molecular dynamic simulations, based on MM-PBSA analysis. Therefore, our results suggest the potential utility of phenyl mannoside derivatives as FimH inhibitors to mitigate urinary tract infections produced by UPEC; thus, decreasing colonization, disease burden, and the costs of medical care.https://www.mdpi.com/2079-6382/10/9/1072UPECFimHmolecular dynamicsvirulence factorsantibiotic resistance
spellingShingle Alfredo Montes-Robledo
Rosa Baldiris-Avila
Johan Fabian Galindo
D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
Antibiotics
UPEC
FimH
molecular dynamics
virulence factors
antibiotic resistance
title D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
title_full D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
title_fullStr D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
title_full_unstemmed D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
title_short D-Mannoside FimH Inhibitors as Non-Antibiotic Alternatives for Uropathogenic <i>Escherichia coli</i>
title_sort d mannoside fimh inhibitors as non antibiotic alternatives for uropathogenic i escherichia coli i
topic UPEC
FimH
molecular dynamics
virulence factors
antibiotic resistance
url https://www.mdpi.com/2079-6382/10/9/1072
work_keys_str_mv AT alfredomontesrobledo dmannosidefimhinhibitorsasnonantibioticalternativesforuropathogeniciescherichiacolii
AT rosabaldirisavila dmannosidefimhinhibitorsasnonantibioticalternativesforuropathogeniciescherichiacolii
AT johanfabiangalindo dmannosidefimhinhibitorsasnonantibioticalternativesforuropathogeniciescherichiacolii